Oncometabolites: A new insight for oncology

doi:10.1002/mgg3.873

Editorial

. 2019 Sep;7(9):e873.

doi: 10.1002/mgg3.873. Epub 2019 Jul 18.

Oncometabolites: A new insight for oncology

Fatemeh Khatami¹, Seyed Mohammad Kazem Aghamir¹, Seyed Mohammad Tavangar^{2

3}

Affiliations

¹ Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
² Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
³ Department of Pathology, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 31321921
PMCID: PMC6732276
DOI: 10.1002/mgg3.873

Editorial

Oncometabolites: A new insight for oncology

Fatemeh Khatami et al. Mol Genet Genomic Med. 2019 Sep.

. 2019 Sep;7(9):e873.

doi: 10.1002/mgg3.873. Epub 2019 Jul 18.

Authors

Fatemeh Khatami¹, Seyed Mohammad Kazem Aghamir¹, Seyed Mohammad Tavangar^{2

3}

Affiliations

¹ Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
² Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
³ Department of Pathology, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 31321921
PMCID: PMC6732276
DOI: 10.1002/mgg3.873

Abstract

The new aspect of oncometabolite can be an indicator of genetic and epigenetic change and cancer biomarker.

PubMed Disclaimer

Cited by

Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
Ambrosini G, Cordani M, Zarrabi A, Alcon-Rodriguez S, Sainz RM, Velasco G, Gonzalez-Menendez P, Dando I. Ambrosini G, et al. Cell Commun Signal. 2024 Jan 12;22(1):36. doi: 10.1186/s12964-023-01462-0. Cell Commun Signal. 2024. PMID: 38216942 Free PMC article. Review.
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies.
Nadhan R, Kashyap S, Ha JH, Jayaraman M, Song YS, Isidoro C, Dhanasekaran DN. Nadhan R, et al. Metabolites. 2023 Apr 30;13(5):618. doi: 10.3390/metabo13050618. Metabolites. 2023. PMID: 37233659 Free PMC article. Review.
Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis.
Niu N, Ye J, Hu Z, Zhang J, Wang Y. Niu N, et al. Int J Mol Sci. 2023 Apr 11;24(8):7076. doi: 10.3390/ijms24087076. Int J Mol Sci. 2023. PMID: 37108242 Free PMC article. Review.
Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review.
Di Sario G, Rossella V, Famulari ES, Maurizio A, Lazarevic D, Giannese F, Felici C. Di Sario G, et al. Front Genet. 2023 Apr 3;14:1152470. doi: 10.3389/fgene.2023.1152470. eCollection 2023. Front Genet. 2023. PMID: 37077538 Free PMC article. Review.
Imaging 2-hydroxyglutarate and other brain oncometabolites pertinent to critical genomic alterations in brain tumors.
Thomas T, Thakur S, Young R. Thomas T, et al. BJR Open. 2023 Mar 22;5(1):20210070. doi: 10.1259/bjro.20210070. eCollection 2023. BJR Open. 2023. PMID: 37035765 Free PMC article. Review.

See all "Cited by" articles

References

1. Alimoghaddam, K. , Shariftabrizi, A. , Tavangar, M. , Sanaat, Z. , Rostami, S. , Jahani, M. , Ghavamzadeh, A. (2006). Anti‐leukemic and anti‐angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia. Leukemia & Lymphoma, 47(1), 81–88. - PubMed
1. Beger, R. D. , Schnackenberg, L. K. , Holland, R. D. , Li, D. , & Dragan, Y. (2006). Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics, 2(3), 125–134. 10.1007/s11306-006-0026-2 - DOI
1. Copeland, R. A. , Harpel, M. R. , & Tummino, P. J. (2007). Targeting enzyme inhibitors in drug discovery. Expert Opinion on Therapeutic Targets, 11(7), 967–978. - PubMed
1. Dando, I. , Pozza, E. D. , Ambrosini, G. , Torrens‐Mas, M. , Butera, G. , Mullappilly, N. , … Donadelli, M. (2019). Oncometabolites in cancer aggressiveness and tumour repopulation. Biological Reviews, 94(4):1530–1546. 10.1111/brv.12513 - DOI - PubMed
1. DeBerardinis, R. J. , & Chandel, N. S. (2016). Fundamentals of cancer metabolism. Science Advances, 2, 5 10.1126/sciadv.1600200 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database

[1] Alimoghaddam, K. , Shariftabrizi, A. , Tavangar, M. , Sanaat, Z. , Rostami, S. , Jahani, M. , Ghavamzadeh, A. (2006). Anti‐leukemic and anti‐angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia. Leukemia & Lymphoma, 47(1), 81–88. - PubMed

[2] Alimoghaddam, K. , Shariftabrizi, A. , Tavangar, M. , Sanaat, Z. , Rostami, S. , Jahani, M. , Ghavamzadeh, A. (2006). Anti‐leukemic and anti‐angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia. Leukemia & Lymphoma, 47(1), 81–88. - PubMed

[3] Beger, R. D. , Schnackenberg, L. K. , Holland, R. D. , Li, D. , & Dragan, Y. (2006). Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics, 2(3), 125–134. 10.1007/s11306-006-0026-2 - DOI

[4] Beger, R. D. , Schnackenberg, L. K. , Holland, R. D. , Li, D. , & Dragan, Y. (2006). Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics, 2(3), 125–134. 10.1007/s11306-006-0026-2 - DOI

[5] Copeland, R. A. , Harpel, M. R. , & Tummino, P. J. (2007). Targeting enzyme inhibitors in drug discovery. Expert Opinion on Therapeutic Targets, 11(7), 967–978. - PubMed

[6] Copeland, R. A. , Harpel, M. R. , & Tummino, P. J. (2007). Targeting enzyme inhibitors in drug discovery. Expert Opinion on Therapeutic Targets, 11(7), 967–978. - PubMed

[7] Dando, I. , Pozza, E. D. , Ambrosini, G. , Torrens‐Mas, M. , Butera, G. , Mullappilly, N. , … Donadelli, M. (2019). Oncometabolites in cancer aggressiveness and tumour repopulation. Biological Reviews, 94(4):1530–1546. 10.1111/brv.12513 - DOI - PubMed

[8] Dando, I. , Pozza, E. D. , Ambrosini, G. , Torrens‐Mas, M. , Butera, G. , Mullappilly, N. , … Donadelli, M. (2019). Oncometabolites in cancer aggressiveness and tumour repopulation. Biological Reviews, 94(4):1530–1546. 10.1111/brv.12513 - DOI - PubMed

[9] DeBerardinis, R. J. , & Chandel, N. S. (2016). Fundamentals of cancer metabolism. Science Advances, 2, 5 10.1126/sciadv.1600200 - DOI - PMC - PubMed

[10] DeBerardinis, R. J. , & Chandel, N. S. (2016). Fundamentals of cancer metabolism. Science Advances, 2, 5 10.1126/sciadv.1600200 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Oncometabolites: A new insight for oncology

Affiliations

Oncometabolites: A new insight for oncology

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources